Customized Eye Care: Combined with a T&E regimen, aflibercept promises to revolutionize treatment of retinal diseases
Separate, independent studies suggest that aflibercept has a longer half-life, greater potency, and better VEGF-A binding affinity than other available…
AI and the Eye: What we need to know about artificial intelligence and big data analytics in ophthalmology
The first symposium on “Artificial Intelligence and Big Data Analytics in Ophthalmology for Global Eye Health: Opportunities and Challenges” kicked…
latest posts